Apellis Pharmaceuticals, Inc. (FRA:1JK)
Germany flag Germany · Delayed Price · Currency is EUR
20.69
+0.03 (0.12%)
At close: Jan 2, 2026

Apellis Pharmaceuticals Market Cap

Apellis Pharmaceuticals has a market cap or net worth of €2.97 billion as of January 9, 2026. Its market cap has decreased by -25.26% in one year.

Market Cap
2.97B
Enterprise Value
2.97B
Revenue
866.28M
Ranking
n/a
PE Ratio
77.45
Stock Price
€20.69

Market Cap Chart

Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from 593.77M to 2.97B, an increase of 400.11%. That is a compound annual growth rate of 21.77%.

History

DateMarket Cap% Change
Jan 9, 20262.97B9.70%
Dec 31, 20252.71B-29.40%
Dec 31, 20243.83B-40.26%
Dec 29, 20236.42B19.95%
Dec 30, 20225.35B32.19%
Dec 31, 20214.05B14.29%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Nov 9, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition